Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based Strategies

Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation... Hepatocellular carcinoma (HCC) is a global killer with preponderance in Asian and African countries. It poses a challenge for successful management in less affluent or developing nations like India, with large populations and limited infrastructures. This review aims to assess the available options and future directions for management of HCC applicable to such countries. While summarizing current and emerging clinical strategies for detection, staging and therapy of the disease, it highlights radioisotope- and radioactivity-based strategies as part of an overall program. Using the widely accepted Barcelona Clinic Liver Cancer (BCLC) staging system as a base, it evaluates the applicability of different therapeutic approaches and their synergistic combination(s) in the context of a patient-specific dynamic results-based strategy. It distills the conclusions of multiple HCC management-focused consensus recommendations to provide a picture of clinical strategies, especially radiation-related approaches. Additionally, it discusses the logistical and economic feasibility of these approaches in the context of the limitations of the burdened public health infrastructure in India (and like nations) and highlights possible strategies both at the clinical level and in terms of an administrative health policy on HCC to provide the maximum possible benefit to the widest swathe of the affected population. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology and Therapy Springer Journals

Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based Strategies

Download PDF
23 pages

Loading next page...
 
/lp/springer-journals/clinical-management-of-liver-cancer-in-india-and-other-developing-agSLNlnmPZ
Publisher
Springer Journals
Copyright
Copyright © The Author(s) 2021
ISSN
2366-1070
eISSN
2366-1089
DOI
10.1007/s40487-021-00154-4
Publisher site
See Article on Publisher Site

Abstract

Hepatocellular carcinoma (HCC) is a global killer with preponderance in Asian and African countries. It poses a challenge for successful management in less affluent or developing nations like India, with large populations and limited infrastructures. This review aims to assess the available options and future directions for management of HCC applicable to such countries. While summarizing current and emerging clinical strategies for detection, staging and therapy of the disease, it highlights radioisotope- and radioactivity-based strategies as part of an overall program. Using the widely accepted Barcelona Clinic Liver Cancer (BCLC) staging system as a base, it evaluates the applicability of different therapeutic approaches and their synergistic combination(s) in the context of a patient-specific dynamic results-based strategy. It distills the conclusions of multiple HCC management-focused consensus recommendations to provide a picture of clinical strategies, especially radiation-related approaches. Additionally, it discusses the logistical and economic feasibility of these approaches in the context of the limitations of the burdened public health infrastructure in India (and like nations) and highlights possible strategies both at the clinical level and in terms of an administrative health policy on HCC to provide the maximum possible benefit to the widest swathe of the affected population.

Journal

Oncology and Therapy – Springer Journals

Published: Dec 1, 2021

Keywords: BCLC; Embolization; Hepatocellular carcinoma; Liver cancer; Radiation therapy; SIRT; TARE

References

  • Hepatitis B and C viruses, their coinfection and correlations in chronic liver disease patients: a tertiary care hospital study
    Grewal, US; Walia, G; Bakshi, R; Chopra, S
  • Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis
    Jiang, HY; Chen, J; Xia, CC; Cao, LK; Duan, T; Song, B
  • HCC with low- and normal-serum alpha-fetoprotein levels
    Carr, BI; Akkiz, H; Üsküdar, O; Yalçın, K; Guerra, V; Kuran, S
  • State of the art in magnetic resonance imaging of hepatocellular carcinoma
    Horvat, N; Monti, S; Oliveira, BC; Rocha, CCT; Giancipoli, RG; Mannelli, L
  • Proton beam therapy for hepatocellular carcinoma: a review of the university of tsukuba experience
    Mizumoto, M; Oshiro, Y; Okumura, T; Fukumitsu, N; Numajiri, H; Ohnishi, K
  • Development of semiautomated module for preparation of 131I labeled lipiodol for liver cancer therapy
    Mukherjee, A; Subramanian, S; Ambade, R; Avhad, B; Dash, A; Korde, A